Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression

por Seymour, John F., Marcus, Robert, Davies, Andrew, Gallop-Evans, Eve, Grigg, Andrew, Haynes, Andrew, Herold, Michael, Illmer, Thomas, Nilsson-Ehle, Herman, Sökler, Martin, Dünzinger, Ulrich, Nielsen, Tina, Launonen, Aino, Hiddemann, Wolfgang
Publicado 2019